Semaglutide for the Treatment of Obesity: A Randomized Controlled Trial
( A L ) Plasma concentrations of GLP-1 (active) ( A ), insulin ( B ), leptin ( C ), PYY ( D ), C-peptide 2 ( E ), GIP (total) ( F ), amylin ( G ), glucagon ( H ), PP ( I ), ghrelin ( J ), resistin ( K ), and secretin ( L ) in 22- to 28-week-old female ad libitum chow-fed WT C57BL/6J and Bbs5 / mice ( n = 5 per group) before and after semaglutide therapy
The list used to be longer, but two medicationssibutramine (Meridia) and lorcaserin (Belviq)were recently withdrawn due to elevated risks of cardiovascular events and cancer, respectively
Sermorelin injections may be prescribed in cases where a clinician is evaluating or addressing growth hormone production